Cargando…

COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy

Introduction: Asthma, along with inhaled steroids, was initially considered a risk factor for worse clinical outcomes in COVID-19. This was related to the higher morbidity observed in asthma patients during previous viral outbreaks. This retrospective study aimed at evaluating the prevalence of asth...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicola, Stefania, Borrelli, Richard, Ridolfi, Irene, Bernardi, Virginia, Borrelli, Paolo, Guida, Giuseppe, Antonelli, Andrea, Albera, Carlo, Marengo, Stefania, Briozzo, Antonio, Norbiato, Claudio, Frazzetto, Agata Valentina, Saad, Marina, Lo Sardo, Luca, Bacco, Beatrice, Gallo Cassarino, Silvia, Della Mura, Stefano, Bagnasco, Diego, Bucca, Caterina, Rolla, Giovanni, Solidoro, Paolo, Brussino, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321539/
https://www.ncbi.nlm.nih.gov/pubmed/35887681
http://dx.doi.org/10.3390/jpm12071184
_version_ 1784756072753397760
author Nicola, Stefania
Borrelli, Richard
Ridolfi, Irene
Bernardi, Virginia
Borrelli, Paolo
Guida, Giuseppe
Antonelli, Andrea
Albera, Carlo
Marengo, Stefania
Briozzo, Antonio
Norbiato, Claudio
Frazzetto, Agata Valentina
Saad, Marina
Lo Sardo, Luca
Bacco, Beatrice
Gallo Cassarino, Silvia
Della Mura, Stefano
Bagnasco, Diego
Bucca, Caterina
Rolla, Giovanni
Solidoro, Paolo
Brussino, Luisa
author_facet Nicola, Stefania
Borrelli, Richard
Ridolfi, Irene
Bernardi, Virginia
Borrelli, Paolo
Guida, Giuseppe
Antonelli, Andrea
Albera, Carlo
Marengo, Stefania
Briozzo, Antonio
Norbiato, Claudio
Frazzetto, Agata Valentina
Saad, Marina
Lo Sardo, Luca
Bacco, Beatrice
Gallo Cassarino, Silvia
Della Mura, Stefano
Bagnasco, Diego
Bucca, Caterina
Rolla, Giovanni
Solidoro, Paolo
Brussino, Luisa
author_sort Nicola, Stefania
collection PubMed
description Introduction: Asthma, along with inhaled steroids, was initially considered a risk factor for worse clinical outcomes in COVID-19. This was related to the higher morbidity observed in asthma patients during previous viral outbreaks. This retrospective study aimed at evaluating the prevalence of asthma among patients admitted due to SARS-CoV-2 infection as well as the impact of inhaled therapies on their outcomes. Furthermore, a comparison between patients with asthma, COPD and the general population was made. Methods: All COVID-19 inpatients were recruited between February and July 2020 from four large hospitals in Northwest Italy. Data concerning medical history, the Charlson Comorbidity Index (CCI) and the hospital stay, including length, drugs and COVID-19 complications (respiratory failure, lung involvement, and the need for respiratory support) were collected, as well as the type of discharge. Results: patients with asthma required high-flow oxygen therapy (33.3 vs. 14.3%, p = 0.001) and invasive mechanical ventilation (17.9 vs. 9.5%, p = 0.048) more frequently when compared to the general population, but no other difference was observed. Moreover, asthma patients were generally younger than patients with COPD (59.2 vs. 76.8 years, p < 0.001), they showed both a lower mortality rate (15.4 vs. 39.4%, p < 0.001) and a lower CCI (3.4 vs. 6.2, p < 0.001). Patients with asthma in regular therapy with ICS at home had significantly shorter hospital stay compared to those with no treatments (25.2 vs. 11.3 days, p = 0.024). Discussion: Our study showed that asthma is not associated with worse outcomes of COVID-19, despite the higher need for respiratory support compared with the general population, while the use of ICS allowed for a shorter hospital stay. In addition, the comparison of asthma with COPD patients confirmed the greater frailty of the latter, according to their multiple comorbidities.
format Online
Article
Text
id pubmed-9321539
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93215392022-07-27 COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy Nicola, Stefania Borrelli, Richard Ridolfi, Irene Bernardi, Virginia Borrelli, Paolo Guida, Giuseppe Antonelli, Andrea Albera, Carlo Marengo, Stefania Briozzo, Antonio Norbiato, Claudio Frazzetto, Agata Valentina Saad, Marina Lo Sardo, Luca Bacco, Beatrice Gallo Cassarino, Silvia Della Mura, Stefano Bagnasco, Diego Bucca, Caterina Rolla, Giovanni Solidoro, Paolo Brussino, Luisa J Pers Med Article Introduction: Asthma, along with inhaled steroids, was initially considered a risk factor for worse clinical outcomes in COVID-19. This was related to the higher morbidity observed in asthma patients during previous viral outbreaks. This retrospective study aimed at evaluating the prevalence of asthma among patients admitted due to SARS-CoV-2 infection as well as the impact of inhaled therapies on their outcomes. Furthermore, a comparison between patients with asthma, COPD and the general population was made. Methods: All COVID-19 inpatients were recruited between February and July 2020 from four large hospitals in Northwest Italy. Data concerning medical history, the Charlson Comorbidity Index (CCI) and the hospital stay, including length, drugs and COVID-19 complications (respiratory failure, lung involvement, and the need for respiratory support) were collected, as well as the type of discharge. Results: patients with asthma required high-flow oxygen therapy (33.3 vs. 14.3%, p = 0.001) and invasive mechanical ventilation (17.9 vs. 9.5%, p = 0.048) more frequently when compared to the general population, but no other difference was observed. Moreover, asthma patients were generally younger than patients with COPD (59.2 vs. 76.8 years, p < 0.001), they showed both a lower mortality rate (15.4 vs. 39.4%, p < 0.001) and a lower CCI (3.4 vs. 6.2, p < 0.001). Patients with asthma in regular therapy with ICS at home had significantly shorter hospital stay compared to those with no treatments (25.2 vs. 11.3 days, p = 0.024). Discussion: Our study showed that asthma is not associated with worse outcomes of COVID-19, despite the higher need for respiratory support compared with the general population, while the use of ICS allowed for a shorter hospital stay. In addition, the comparison of asthma with COPD patients confirmed the greater frailty of the latter, according to their multiple comorbidities. MDPI 2022-07-20 /pmc/articles/PMC9321539/ /pubmed/35887681 http://dx.doi.org/10.3390/jpm12071184 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Nicola, Stefania
Borrelli, Richard
Ridolfi, Irene
Bernardi, Virginia
Borrelli, Paolo
Guida, Giuseppe
Antonelli, Andrea
Albera, Carlo
Marengo, Stefania
Briozzo, Antonio
Norbiato, Claudio
Frazzetto, Agata Valentina
Saad, Marina
Lo Sardo, Luca
Bacco, Beatrice
Gallo Cassarino, Silvia
Della Mura, Stefano
Bagnasco, Diego
Bucca, Caterina
Rolla, Giovanni
Solidoro, Paolo
Brussino, Luisa
COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
title COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
title_full COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
title_fullStr COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
title_full_unstemmed COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
title_short COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy
title_sort copd, but not asthma, is associated with worse outcomes in covid-19: real-life data from four main centers in northwest italy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321539/
https://www.ncbi.nlm.nih.gov/pubmed/35887681
http://dx.doi.org/10.3390/jpm12071184
work_keys_str_mv AT nicolastefania copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT borrellirichard copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT ridolfiirene copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT bernardivirginia copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT borrellipaolo copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT guidagiuseppe copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT antonelliandrea copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT alberacarlo copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT marengostefania copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT briozzoantonio copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT norbiatoclaudio copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT frazzettoagatavalentina copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT saadmarina copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT losardoluca copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT baccobeatrice copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT gallocassarinosilvia copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT dellamurastefano copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT bagnascodiego copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT buccacaterina copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT rollagiovanni copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT solidoropaolo copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly
AT brussinoluisa copdbutnotasthmaisassociatedwithworseoutcomesincovid19reallifedatafromfourmaincentersinnorthwestitaly